EICHOR
● Active Not Recruiting
Portico Next Generation Approval Study
Condition: Symptomatic Severe Aortic Stenosis · Sponsor: Abbott Medical Devices
About this study
The purpose of this clinical study is to evaluate the acute safety and effectiveness of the next-generation Navitor (Portico™ NG) Transcatheter Aortic Heart Valve as assessed by the rate of all-cause mortality at 30 days and the rate of moderate or greater paravalvular leak at 30 days in a high or extreme surgical risk patient population to support CE (Conformité Européenne) Mark and FDA approval.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (28)
| Cedars-Sinai Medical Center | Los Angeles, California, United States | — |
| Los Robles Regional Medical Center | Thousand Oaks, California, United States | — |
| Washington Hospital Center | Washington D.C., District of Columbia, United States | — |
| Advocate Christ Medical Center | Oak Lawn, Illinois, United States | — |
| St. Vincent Hospital | Indianapolis, Indiana, United States | — |
| Via Christi Regional Medical Center | Wichita, Kansas, United States | — |
| Sparrow Clinical Research Institute | Lansing, Michigan, United States | — |
| Minneapolis Heart Institute | Minneapolis, Minnesota, United States | — |
| Atlantic Health System - Morristown Memorial Hospital | Morristown, New Jersey, United States | — |
| Albany Medical Center | Albany, New York, United States | — |
| Columbia University Medical Center/NYPH | New York, New York, United States | — |
| Montefiore Medical Center - Moses Division | New York, New York, United States | — |
+ 16 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04011722